Skip to content

Medical Action Industries, Inc. 306

United Statesfrom the FDA registration address FDA establishment FEI 1030451

Devices
0
Registrations
FDA
FDA recalls
66 ongoing

No devices from this company are in the catalogue yet.

Company details

FDA FEI number
1030451
Address
25 HEYWOOD RD., ARDEN, NC, 28704

FDA recalls6

Recalls are matched to the firm by name. FDA recall data as of 22 Oct 2026.

Recalls initiated per year

  • 2017 0
  • 2018 0
  • 2019 0
  • 2020 0
  • 2021 0
  • 2022 0
  • 2023 0
  • 2024 0
  • 2025 0
  • 2026 6

  • 2026

    • 23 Jul 2026 Z-3106-2026 Class I Ongoing Kits containing Sodium Chloride ampules subject to another recall are recalled due to potentially compromised sterility. Distribution: US distribution to states of: IA, VA, MO, KS, FL, OH and LS.
    • 23 Jul 2026 Z-3107-2026 Class I Ongoing Kits containing Sodium Chloride ampules subject to another recall are recalled due to potentially compromised sterility. Distribution: US distribution to states of: IA, VA, MO, KS, FL, OH and LS.
    • 23 Jul 2026 Z-3181-2026 Class II Ongoing Blood culture convenience kits contain a component subject to a drug recall that due to an an open or incomplete seal on the packaging of the applicator may compromise the component's sterile barrier and if used may lead to localized skin or soft tissue infection. Distribution: US Nationwide distribution in the states of OH, IN, NC.
    • 9 Jul 2026 Z-0069-2027 Class III Ongoing An internal data-entry error caused kit lot 333606 to be labeled with an expiration date of March 31, 2027, instead of February 28, 2027. Distribution: U.S.: CA O.U.S.: N/A
    • 21 May 2026 Z-2858-2026 Class II Ongoing Convenience kits contain needle free access device that has an improper seal which may result in doming or tearing of the silicone seal. Distribution: US Nationwide distribution in the state of CA.
    • 13 May 2026 Z-2792-2026 Class I Ongoing Cardiovascular procedure kits contain manifolds, the subject of another recall, that may have particulate within the fluid path, which has the potential to be introduced into blood circulation and become lodged within blood vessels. Distribution: US: AZ, CO

This is an FDA establishment record without devices in deviCERTS.